SC Ropharma (BSE:RPH) Change In Receivables: lei-70.2 Mil (TTM As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:RPH SC Ropharma SA BSE:RPH
66 GF Score
Price lei0.22
View Full Analysis

What is SC Ropharma Change In Receivables?

SC Ropharma BSE:RPH 66 Change In Receivables is lei-70.2 Mil as of Dec. 2024. GuruFocus rates BSE:RPH with a GF Score™ of 66/100.

SC Ropharma's change in receivables for the quarter that ended in Dec. 2024 was lei-53.6 Mil. It means SC Ropharma's Accounts Receivable increased by lei53.6 Mil from Jun. 2024 to Dec. 2024 .

SC Ropharma's change in receivables for the fiscal year that ended in Dec. 2024 was lei-70.2 Mil. It means SC Ropharma's Accounts Receivable increased by lei70.2 Mil from Dec. 2023 to Dec. 2024 .

SC Ropharma's Accounts Receivable for the quarter that ended in Dec. 2024 was lei320.3 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SC Ropharma's Days Sales Outstanding for the six months ended in Dec. 2024 was 83.86.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SC Ropharma's liquidation value for the six months ended in Dec. 2024 was lei-314.6 Mil.

SC Ropharma  (BSE:RPH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SC Ropharma's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=320.344363/697.12003*91
=83.86

2. In Ben Graham's calculation of liquidation value, SC Ropharma's accounts receivable are only considered to be worth 75% of book value:

SC Ropharma's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=19.902405-688.416562+0.75 * 320.344363+0.5 * 227.409182
=-314.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SC Ropharma Change In Receivables Related Terms

SC Ropharma Change In Receivables Historical Data

* Premium members only.

The historical data trend for SC Ropharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SC Ropharma Change In Receivables Chart

SC Ropharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.38 -4.22 -45.45 4.90 -70.17

SC Ropharma Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.15 7.90 -3.00 -16.55 -53.62
BSE:RPH
66GF Score
SC Ropharma SA BSE:RPH
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SC Ropharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was lei-70.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of lei-70.2 Mil mean?
SC Ropharma (BSE:RPH) has a Change In Receivables of lei-70.2 Mil as of Dec. 2024. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for SC Ropharma and its competitors.
Is SC Ropharma's Change In Receivables too high?
SC Ropharma's current Change In Receivables is lei-70.2 Mil. Overall, SC Ropharma has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does SC Ropharma's Change In Receivables compare to competitors?
SC Ropharma's Change In Receivables of lei-70.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for SC Ropharma and its competitors. SC Ropharma's current Change In Receivables is lei-70.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SC Ropharma stock overvalued right now?
SC Ropharma (BSE:RPH) has a current Change In Receivables of lei-70.2 Mil. The current Change In Receivables is lei-70.2 Mil. SC Ropharma's overall GF Score™ is 66/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For SC Ropharma (BSE:RPH), the current Change In Receivables is lei-70.2 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SC Ropharma Business Description

Address Strada Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
66GF Score

Get the complete analysis for BSE:RPH

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.22
Price